Tag: Daniel Tenen
-
Nation & World
Developing cancer drugs
Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.
-
Nation & World
Study identifies mechanism of resistance to targeted therapy in lung cancer patients
Gefitinib acts on the receptor for the epidermal growth factor protein (EGFR) to halt the spread of cancer cells by fitting into the activating pocket of the protein, blocking the…